Glenn Heller

Treatment of Diamond-Blackfan anemia with recombinant human interleukin-3.

B. Alter, G. Heller, J. Lipton, 1993, Blood.

Statistical controversies in clinical research: an initial evaluation of a surrogate end point using a single randomized clinical trial and the Prentice criteria.

G. Heller, Glenn Heller, 2015, Annals of oncology : official journal of the European Society for Medical Oncology.

Paclitaxel, estramustine phosphate, and carboplatin in patients with advanced prostate cancer.

P. Kantoff, S. Larson, H. Scher, 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

N7: a novel multi-modality therapy of high risk neuroblastoma (NB) in children diagnosed over 1 year of age.

W. Gerald, J. Mora, G. Heller, 2001, Medical and pediatric oncology.

Stage 4 neuroblastoma diagnosed at more than 1 year of age: gross total resection and clinical outcome.

G. Heller, B. Kushner, M. Bonilla, 1994, Journal of pediatric surgery.

Risk of disease recurrence and second neoplasms in survivors of childhood cancer treated with growth hormone: a report from the Childhood Cancer Survivor Study.

L. Robison, A. Mertens, P. Mitby, 2002, The Journal of clinical endocrinology and metabolism.

Hyperfractionated low-dose radiotherapy for high-risk neuroblastoma after intensive chemotherapy and surgery.

G. Heller, M. LaQuaglia, S. Wolden, 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Response of prostate cancer to anti-Her-2/neu antibody in androgen-dependent and -independent human xenograft models.

C. Cordon-Cardo, H. Scher, D. Agus, 1999, Cancer research.

Prognostic factors and outcome in patients 21 years and under with colorectal carcinoma.

W. Enker, G. Heller, M. LaQuaglia, 1992, Journal of pediatric surgery.